Results
6
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
6 companies
Gushengtang Holdings
Market Cap: HK$9.1b
An investment holding company, provides healthcare services in the People’s Republic of China.
2273
HK$38.35
7D
6.4%
1Y
-8.8%
MicroPort CardioFlow Medtech
Market Cap: HK$2.2b
A medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally.
2160
HK$0.93
7D
10.7%
1Y
-2.1%
Beijing Chunlizhengda Medical Instruments
Market Cap: HK$6.4b
Beijing Chunlizhengda Medical Instruments Co., Ltd.
1858
HK$11.46
7D
7.5%
1Y
22.4%
Jiangxi Rimag Group
Market Cap: HK$5.3b
Invests and operates medical imaging centers in China.
2522
HK$14.48
7D
-14.8%
1Y
-3.5%
Acotec Scientific Holdings
Market Cap: HK$2.5b
Operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China and internationally.
6669
HK$7.98
7D
2.4%
1Y
5.7%
MicroPort NeuroScientific
Market Cap: HK$7.3b
Engages in the research and development, production, and sale of neuro-interventional medical devices in the People’s Republic of China and internationally.
2172
HK$12.64
7D
23.7%
1Y
50.7%